ZBIO
Zenas BioPharma, Inc.
NASDAQ · USHealthcareBiotechnology
$30.70+3.96%
Price as of Jul 20, 2026
ZBIO valuation
Zenas BioPharma, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 17.05x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.77x
- Price / sales
- —
- Price / cash flow
- -9.21x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- —
- EV / EBITDA
- -3.85x
- EV / EBIT
- -3.72x
- Market cap
- $1.9B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.